Skip to main content
Premium Trial:

Request an Annual Quote

Eksigent Licenses Microfluidics Technologies from Sandia Labs

NEW YORK, Aug 14 – Eksigent Technologies has announced that it has licensed Sandia National Laboratories’ microfluidics technology.

Eksigent and Sandia, both of Livermore, Calif., did not disclose the terms of the deal or describe the specific technologies involved. Sandia licensed Eksigent the technology through its tech transfer program.

Eksigent, which is developing the EKPump, an electrokinetic pump that uses an applied electric field to generate fluid flow and high pressures, said that it would initially use Sandia’s technology in its microfluidics system.

The technology could also be applied to proteomics and chemical analysis, the company said.

"Combined with additional efforts at Eksigent, this technology will soon be ready for integration into commercial products," Don Arnold, cofounder of Eksigent, said in a statement. 

Eksigent’s technical staff previously worked at Sandia, developing microfluidics systems. In July, Eksigent announced a deal to work with Beckman Coulter to jointly look for ways to incorporate its microfluidics technology into Beckman Coulter’s instruments. 

The Sandia lab, part of the US Department of Energy, conducts research in national security, energy, and environmental technologies.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.